
Opinion|Videos|February 25, 2025
Patient Voices: Shaping the Future of PNH Care
Author(s)David Dingli, MD, PhD, Brandi Lewis
Panelists discuss how their lived experiences and insights as patients should inform research priorities, treatment development, and care delivery improvements while sharing hopes for a future cure that would eliminate ongoing disease management needs and allow greater life flexibility.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What role do you think patient voices should play in guiding future advancements in paroxysmal nocturnal hemoglobinuria (PNH) care?
- How do you imagine your life might change if there were a cure for PNH in the future?
This program was made possible with support from Novartis Pharmaceuticals.
Advertisement
Related to this article

JoAnne Page, RN, a breast cancer survivor, shares what oncology nurses can do for care partners of patients with bladder cancer.

Lisa Carter-Bawa, PhD, MPH, APRN, explains how blame keeps patients from lung cancer care and how nurses can counter that stigma in the community.

At the 10th Annual School of Nursing Oncology, faculty said nurses need fast, disease-specific updates to educate patients and manage novel therapies.

Experts detail evidence for exercise, acupuncture, and mind-body care during radiation, and the knowledge and referral gaps that limit uptake.

Coral Omene, MD, PhD, discusses the clinical impact of breast cancer disparities and how oncology nurses can support diverse trial recruitment.

An ONS review presented at EONS19 outlines 7 system-level employer strategies to curb oncology nurse burnout and improve retention.

A Columbia nurse scientist shares her takeaways from the 2026 ASCO Quality Care Symposium, from geriatric assessment to care across the age span.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Giredestrant Plus Everolimus for ESR1-Mutated Breast Cancer
2
FDA Declines Ivonescimab Approval in EGFR+ NSCLC Over Survival Data
3
FDA Grants Accelerated Approval to Neladalkib in Pretreated ALK+ NSCLC
4
FDA Approves Pertuzumab Biosimilar Pebrilzo for HER2+ Breast Cancer
5

